Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
1999 9
2000 6
2001 6
2002 9
2003 5
2004 9
2005 6
2006 10
2007 10
2008 3
2009 6
2010 2
2011 1
2012 4
2013 3
2014 4
2015 3
2016 7
2017 7
2018 12
2019 17
2020 9
2021 7
2022 7
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Results by year

Filters applied: . Clear all
Page 1
Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes.
Violet J, Jackson P, Ferdinandus J, Sandhu S, Akhurst T, Iravani A, Kong G, Kumar AR, Thang SP, Eu P, Scalzo M, Murphy D, Williams S, Hicks RJ, Hofman MS. Violet J, et al. Among authors: akhurst t. J Nucl Med. 2019 Apr;60(4):517-523. doi: 10.2967/jnumed.118.219352. Epub 2018 Oct 5. J Nucl Med. 2019. PMID: 30291192 Free article. Clinical Trial.
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study.
Hofman MS, Violet J, Hicks RJ, Ferdinandus J, Thang SP, Akhurst T, Iravani A, Kong G, Ravi Kumar A, Murphy DG, Eu P, Jackson P, Scalzo M, Williams SG, Sandhu S. Hofman MS, et al. Among authors: akhurst t. Lancet Oncol. 2018 Jun;19(6):825-833. doi: 10.1016/S1470-2045(18)30198-0. Epub 2018 May 8. Lancet Oncol. 2018. PMID: 29752180 Clinical Trial.
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial.
Buteau JP, Martin AJ, Emmett L, Iravani A, Sandhu S, Joshua AM, Francis RJ, Zhang AY, Scott AM, Lee ST, Azad AA, McJannett MM, Stockler MR, Williams SG, Davis ID, Hofman MS; TheraP Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Buteau JP, et al. Lancet Oncol. 2022 Nov;23(11):1389-1397. doi: 10.1016/S1470-2045(22)00605-2. Epub 2022 Oct 16. Lancet Oncol. 2022. PMID: 36261050 Clinical Trial.
Lung cancer.
Akhurst T, MacManus M, Hicks RJ. Akhurst T, et al. PET Clin. 2015 Apr;10(2):147-58. doi: 10.1016/j.cpet.2014.12.002. Epub 2015 Feb 18. PET Clin. 2015. PMID: 25829084 Review.
Staging of Non-Small-Cell Lung Cancer.
Akhurst T. Akhurst T. PET Clin. 2018 Jan;13(1):1-10. doi: 10.1016/j.cpet.2017.09.004. Epub 2017 Oct 26. PET Clin. 2018. PMID: 29157380 Review.
Lung Cancer.
Cheng G, Akhurst T. Cheng G, et al. Among authors: akhurst t. PET Clin. 2018 Jan;13(1):xi-xii. doi: 10.1016/j.cpet.2017.10.001. Epub 2017 Oct 20. PET Clin. 2018. PMID: 29157391 No abstract available.
Correction to: 18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors.
Michaud L, Beattie BJ, Akhurst T, Dunphy M, Zanzonico P, Finn R, Mauguen A, Schöder H, Weber WA, Lassman AB, Blasberg R. Michaud L, et al. Among authors: akhurst t. Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):4. doi: 10.1007/s00259-019-04514-1. Eur J Nucl Med Mol Imaging. 2020. PMID: 31492997 Free PMC article.
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial.
Hofman MS, Emmett L, Sandhu S, Iravani A, Buteau JP, Joshua AM, Goh JC, Pattison DA, Tan TH, Kirkwood ID, Ng S, Francis RJ, Gedye C, Rutherford NK, Weickhardt A, Scott AM, Lee ST, Kwan EM, Azad AA, Ramdave S, Redfern AD, Macdonald W, Guminski A, Hsiao E, Chua W, Lin P, Zhang AY, Stockler MR, Williams SG, Martin AJ, Davis ID; TheraP Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Hofman MS, et al. Lancet Oncol. 2024 Jan;25(1):99-107. doi: 10.1016/S1470-2045(23)00529-6. Epub 2023 Nov 30. Lancet Oncol. 2024. PMID: 38043558 Clinical Trial.
PET/CT colonography.
Gollub MJ, Akhurst T. Gollub MJ, et al. Among authors: akhurst t. J Nucl Med. 2010 Sep;51(9):1489-90; author reply 1490-1. doi: 10.2967/jnumed.110.079632. Epub 2010 Aug 18. J Nucl Med. 2010. PMID: 20720047 Free article. No abstract available.
Update on colorectal cancer imaging.
Gollub MJ, Schwartz LH, Akhurst T. Gollub MJ, et al. Among authors: akhurst t. Radiol Clin North Am. 2007 Jan;45(1):85-118. doi: 10.1016/j.rcl.2006.10.003. Radiol Clin North Am. 2007. PMID: 17157625 Review.
144 results